KRDS peptide

synthetic tetrapeptide derived from lactotransferrin (residues 39 to 42); inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-Stimulated platelets and megakaryocytes

Also Known As:

KRDS tetrapeptide; Lys-Arg-Asp-Ser; lysine-arginine-aspartic acid-serine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Serine Proteases: 3726
        Serine Endopeptidases: 11
        Lactoferrin: 2659
        KRDS peptide: 1
      - Endopeptidases: 633
        Serine Endopeptidases: 11
        Lactoferrin: 2659
        KRDS peptide: 1
Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Lactoferrin: 2659
      - KRDS peptide: 1
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Peptide Fragments: 373
    - KRDS peptide: 1

Related Diseases

1.	Thrombosis (Thrombus) 01/01/1992 - "KRDS (Lys-Arg-Asp-Ser), a tetrapeptide from human lactotransferrin, was tested for its effects in vitro on dog platelet function and in vivo on femoral arterial thrombus formation in dogs. "

Related Drugs and Biologics

1.	Lactoferrin